NCT01682941 2023-11-22
Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen
Ohio State University Comprehensive Cancer Center
Phase NA Completed
Clinical Trials
10 trialsNCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00064194 2020-04-03
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
Canadian Cancer Trials Group
Phase 3 Completed
NCT00345813 2018-08-10
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00031746 2016-07-19
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00078923 2014-03-05
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00765479 2013-09-20
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT00003367 2013-06-26
Diet and PSA Levels in Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00243048 2013-04-05
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00042731 2012-09-24
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed